Production of the anti-G-quadruplex antibody BG4 for efficient genome-wide analyses: From plasmid quality control to antibody validation
Methods in Enzymology · 2024
DOI: 10.1016/bs.mie.2023.11.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Methods in Enzymology, 2024. Verfasst von Ilaria Maurizio und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, University of Padua, Padua, Italy. Hauptthemen laut MEDLINE: DNA, G-Quadruplexes. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
G-quadruplexes (G4s) are non-canonical nucleic acids secondary structures that can form at guanine-rich sequences of DNA and RNA in every kingdom of life. At the DNA level, G4s can form throughout genomes but they are prevalently found in promoter regions and at telomeres, and they have been attributed functions spanning from transcriptional regulation, to control of DNA replication, to maintenance of chromosome ends. Our understanding of the functions of G4s in cells has greatly improved with the development of specific anti-G4 antibodies, which allow the visualization of G4s by immunofluorescence but also the mapping of these secondary DNA structures genome wide. Whole genome identification of the location and abundance of G4s with techniques such as Chromatin Immunoprecipitation coupled with sequencing (ChIP-Seq) and Cleavage Under Target and Tagmentation (CUT&Tag) has allowed the profiling of G4 distribution across distinct cell types and deepen the understanding of G4 functions, particularly in the regulation of transcription. Crucial for these types of genome-wide studies is the availability of an anti-G4 antibody preparation with high affinity and specificity. Here, we describe a protocol for the expression and purification of the anti-DNA G4 structure antibody (BG4) first developed by the Balasubramanian group, which has been proven to selectively recognize G4 structures both in vitro and within cells, and which has great applicability in high-throughput techniques. We provide a detailed, step-by-step protocol to obtain active BG4 starting from a commercially available expression plasmid. We also describe three different approaches to validate the activity of the BG4 preparation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Medicine, University of Padua, Padua, Italy.
- Department of Molecular Medicine, University of Padua, Padua, Italy; Microbiology and Virology Unit, Padua University Hospital, Padua, Italy. Electronic address: sara.richter@unipd.it.
Zitieren
APA
Maurizio, I., Tosoni, B., Gallina, I., Ruggiero, E., Zanin, I., & Richter, S. N. (2024). Production of the anti-G-quadruplex antibody BG4 for efficient genome-wide analyses: From plasmid quality control to antibody validation. Methods in Enzymology. https://doi.org/10.1016/bs.mie.2023.11.004
Vancouver
Maurizio I, Tosoni B, Gallina I, Ruggiero E, Zanin I, Richter SN. Production of the anti-G-quadruplex antibody BG4 for efficient genome-wide analyses: From plasmid quality control to antibody validation. Methods in Enzymology. 2024. doi:10.1016/bs.mie.2023.11.004
BibTeX
@article{Maurizio2024,
author = {Maurizio, Ilaria and Tosoni, Beatrice and Gallina, Irene and Ruggiero, Emanuela and Zanin, Irene and Richter, Sara N},
title = {Production of the anti-G-quadruplex antibody BG4 for efficient genome-wide analyses: From plasmid quality control to antibody validation},
journal = {Methods in Enzymology},
year = {2024},
doi = {10.1016/bs.mie.2023.11.004}
}
EUVIMED